drugset / Trial / NCT01866566

The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination

NCT01866566

RandomizedParallel-groupOpen-labelPrevention

Summary

Through evaluating the immunogenicity and safety for Varicella vaccine two doses immune procedure we could supply scientific and practical evidence for this two doses immune procedure promotion and management.

Timeline

Start
2013-06
Primary completion
2014-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Varicella vaccine Vaccine 0.5 ml
Comparator HBV Unknown 0.5 ml

Indications